Next-generation vectors for drug delivery

The Best balance Biosafety / Efficacy
High Stability for in vivo use
Large Cargo capacity

Technology platforms

DNA vector systems
Integrating & Non-Integrating platform

RNA vector systems
Proprietary platform

Protein vector systems

Open innovation for biotherapy

R&D

GEG Tech establishes research programs using its platform with academic and industrial groups for.

New therapies

Using our technology platform, a wide range of therapeutic approaches can be deployed such as gene therapy, immunotherapy or vaccination.

Genome editing

GEG Tech designs new efficient and safe genome editor vectors

Gene therapy

GEG Tech platforms are enabling the design of the next generation of gene therapies and focuses specifically on biosafety

Cancer immunotherapy

GEG Tech technology platforms open new avenues to genetically engineer immune cells with unprecedented efficacy

Vaccination

GEG Tech technology platforms offer a powerful way to develop the next generations of nucleic acid-based vaccines

Ready to use vectors

The most Powerful & Customizable lentiviral vectors to boost your R&D

Genetically Modified Models

Cellular models

GEG Tech provides custom standard & complex cell lines

Animal models

GEG Tech provides custom standard & complex animal models

Bioproduction

GEG Tech platforms enable the high-level production of standard & complex recombinant proteins

Next-generation vectors for drug delivery

Technology platforms

Open innovation for biotherapy

R&D

New therapies

Genome editing

Gene therapy

Cancer immunotherapy

Vaccination

Ready to use vectors

Genetically Modified Models

Cellular models

Animal models

Bioproduction

Recent News about GEG Tech

Release of new mRNA vectors for prime & base editing

We moved our Lab facility at Spartners by Servier and Biolabs

Innovative Nanoparticles for ex vivo and in vivo Genome Editing

Technologies

Application Areas

COMPANY

SOCIAL